Kalexo Bio: A New Era in siRNA Therapy for Cardiovascular Health Mabwell and Aditum Bio have joined forces to create Kalexo Bio, aiming to advance siRNA therapy for cardiovascular disorders through innovative research.

Kalexo Bio: A New Era in siRNA Therapy for Cardiovascular Health #None #siRNA_therapy #Aditum_Bio #Mabwell_Biotech